Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 5, 2010, Pages 412-420

  Ho, Jenny ^a   Huang, Yi ^a   Danquah, Michael K ^a   Wang, Huanting ^a   Forde, Gareth M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Composite microspheres; Heterologous vaccine; Mesoporous silica spheres; Plasmid DNA; Protein boost

Indexed keywords

BOVINE SERUM ALBUMIN; DNA VACCINE; ENHANCED GREEN FLUORESCENT PROTEIN; MICROSPHERE; PLASMID DNA; POLYETHYLENEIMINE; POLYGLACTIN; POLYMER; SILICON DIOXIDE;

ARTICLE; BIODEGRADABILITY; COMPOSITE MATERIAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; FLOW RATE; IN VITRO STUDY; PARTICLE SIZE; POROSITY; PRECIPITATION; PRIORITY JOURNAL; REPRODUCIBILITY; SCALE UP; STRUCTURE ANALYSIS; VOLUMETRY;

DRUG COMPOUNDING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PLASMIDS; POLYMERS; SERUM ALBUMIN, BOVINE; SILICON DIOXIDE; VACCINES, DNA;

EID: 77549088469     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.01.011     Document Type: Article

References (44)

1. Alpar H.O., and Bramwell V.W. Current status of DNA vaccines and their route of administration. Crit. Rev. Ther. Drug Carr. Syst. 19 (2002) 307-383
2. Avvaru B., Patil M.N., Gogate P.R., and Pandit A.B. Ultrasonic atomization: effect of liquid phase properties. Ultrasonics 44 (2006) 146-158
3. Bellman R., and Pennington R.H. Effects of surface tension and viscosity on Taylor instability. Quart. Appl. Math. 12 (1954) 151-162
4. Bivas-Benita M., Romeijn S., Junginger H.E., and Borchard G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur. J. Pharm. Biopharm. 58 (2004) 1-6
5. Bramwell V.W., and Perrie Y. Particulate delivery systems for vaccines. Crit. Rev. Ther. Drug Carr. Syst. 22 (2005) 151-214
6. Castellanos I.J., Carrasquillo K.G., Lopez J.D., Alvarez M., and Griebenow K. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. J. Pharm. Pharmacol. 53 (2001) 167-178
7. Ciombor D.M., Jaklenec A., Liu A.Z., Thanos C., Rahman N., Weston P., Aaron R., and Mathiowitz E. Encapsulation of BSA using a modified W/O/O emulsion solvent removal method. J. Microencapsul. 23 (2006) 183-194
8. De Rosa G., Quaglia F., La Rotonda M.I., Appel M., Alphandary H., and Fattal E. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. J. Pharm. Sci. 91 (2002) 790-799
9. Felder C.B., Blanco-Prieto M.J., Heizmann J., Merkle H.P., and Gander B. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters. J. Microencapsul. 20 (2003) 553-567
10. Forde G.M., Friend J., and Williamson T. Straightforward biodegradable nanoparticle generation through megahertz-order ultrasonic atomization. Appl. Phys. Lett. 89 (2006) 3
11. Freitas S., Merkle H.P., and Gander B. Ultrasonic atomisation into reduced pressure atmosphere-envisaging aseptic spray-drying for microencapsulation. J. Contr. Release 95 (2004) 185-195
12. Freitas S., Merkle H.P., and Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J. Contr. Release 102 (2005) 313-332
13. Giunchedi P., Alpar H.O., and Conte U. PDLLA microspheres containing steroids: spray-drying, o/w and w/o/w emulsifications as preparation methods. J. Microencapsul. 15 (1998) 185-195
14. Hamman J.H., Enslin G.M., and Kotze A.F. Oral delivery of peptide drugs-barriers and developments. Biodrugs 19 (2005) 165-177
15. Ho J., Danquah M.K., Wang H.T., and Forde G.M. Protein loaded mesoporous silica spheres as a controlled delivery platform. J. Chem. Technol. Biotechnol. 83 (2008) 351-358
16. Ho J., Wang H.T., and Forde G.M. Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization. Biotechnol. Bioeng. 101 (2008) 172-181
17. Ho J., Zhu W., Wang H.T., and Forde G.M. Mesoporous silica spheres from colloids. J. Colloid Interf. Sci. 308 (2007) 374-380
18. Hsieh M.K., Wu C.C., and Lin T.L. Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease. Vaccine 25 (2007) 5417-5427
19. Kippax P., and Francassi J. Particle Size Characterisation in Nasal Sprays and Aerosols. February/March edition (2003), LabPlus International
20. Kneuer C., Sameti M., Bakowsky U., Schiestel T., Schirra H., Schmidt H., and Lehr C.M. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjugate Chem. 11 (2000) 926-932
21. Kneuer C., Sameti M., Haltner E.G., Schiestel T., Schirra H., Schmidt H., and Lehr C.M. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int. J. Pharm. 196 (2000) 257-261
22. Lang R.J. Ultrasonic atomization of liquids. J. Acoust. Soc. Am. 34 (1962) 6-8
23. Lu S. Heterologous prime-boost vaccination. Curr. Opin. Immunol. 21 (2009) 346-351
24. Lu S., Wang S.X., and Grimes-Serrano J.M. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines 7 (2008) 175-191
25. Lungwitz U., Breunig M., Blunk T., and Gopferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60 (2005) 247-266
26. Luo D., and Saltzman W.M. Nonviral gene delivery-thinking of silica. Gene Ther. 13 (2006) 585-586
27. Manoj S., Babiuk L.A., and Littel-van den Hurk S.V. Approaches to enhance the efficacy of DNA vaccines. Crit. Rev. Clin. Lab. Sci. 41 (2004) 1-39
28. Mochida T. Ultrasonic Atomization of Liquids (1978) pp. 193-200
29. Moingeon P., de Taisne C., and Almond J. Delivery technologies for human vaccines. Br. Med. Bull. 62 (2002) 29-44
30. Nakaoka R., Inoue Y., Tabata Y., and Ikada Y. Size effect on the antibody production induced by biodegradable microspheres containing antigen. Vaccine 14 (1996) 1251-1256
31. Newman S.P., Pitcairn G.R., and Dalby R.N. Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit. Rev. Ther. Drug Carr. Syst. 21 (2004) 21-66
32. Pavanetto F., Genta I., Giunchedi P., and Conti B. Evaluation of spray-drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. J. Microencapsul. 10 (1993) 487-497
33. Rajan R., and Pandit A.B. Correlations to predict droplet size in ultrasonic atomisation. Ultrasonics 39 (2001) 235-255
34. Ruberti M., Lima K.D., Dos Santos S.A., Brandao I.T., Soares E.G., Silva C.L., and Junior J.M.R. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. J. Drug Target 12 (2004) 195-203
35. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., Becker M., Sinden R., Smith G.L., and Hill A.V.S. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4 (1998) 397-402
36. Schneider J., Gilbert S.C., Hannan C.M., Degano P., Prieur E., Sheu E.G., Plebanski M., and Hill A.V.S. Induction of CD8(+) T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170 (1999) 29-38
37. Sedegah M., Hedstrom R., Hobart P., and Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protien. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9866-9870
38. Sin J.I., Bagarazzi M., Pachuk C., and Weiner D.B. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol. 18 (1999) 771-779
39. Smith K.A., Tam V.L., Wong R.M., Pagarigan R.R., Meisenburg B.L., Joea D.K., Liu X.P., Sanders C., Diamond D., Kundig T.M., Qiu Z.Y., and Bot A. Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 27 (2009) 2603-2615
40. Spearman P. Current progress in the development of HIV vaccines. Curr. Pharm. Des. 12 (2006) 1147-1167
41. Ulmer J.B., Sadoff J.C., and Liu M.A. DNA vaccines. Curr. Opin. Immunol. 8 (1996) 531-536
42. Weeratna R.D., McCluskie M.J., Comanita L., Wu T., and Davis H.L. Optimization strategies for DNA vaccines. Intervirology 43 (2000) 218-226
43. Xue J.M., and Shi M. PLGA/mesoporous silica hybrid structure for controlled drug release. J. Contr. Release 98 (2004) 209-217
44. Zhao D.Y., Feng J.L., Huo Q.S., Melosh N., Fredrickson G.H., Chmelka B.F., and Stucky G.D. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279 (1998) 548-552